Exelon Co. (NASDAQ:EXC) Receives $45.13 Consensus PT from Analysts

Exelon Co. (NASDAQ:EXC) has been given a consensus rating of “Hold” by the nine ratings firms that are covering the company, Marketbeat.com reports. Five equities research analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $45.63.

Several research firms have recently weighed in on EXC. Guggenheim upgraded Exelon from a “neutral” rating to a “buy” rating in a research note on Thursday, January 23rd. Barclays raised their price target on shares of Exelon from $42.00 to $48.00 and gave the company an “overweight” rating in a report on Tuesday, February 25th. BMO Capital Markets restated an “outperform” rating on shares of Exelon in a research report on Tuesday, February 4th. Scotiabank boosted their target price on shares of Exelon from $42.00 to $44.00 and gave the company a “sector perform” rating in a research note on Thursday, February 13th. Finally, UBS Group raised their price target on Exelon from $45.00 to $47.00 and gave the stock a “neutral” rating in a research note on Friday, March 21st.

Exelon Trading Down 2.2 %

NASDAQ EXC opened at $46.23 on Tuesday. The stock’s fifty day moving average price is $44.42 and its 200-day moving average price is $40.85. The company has a current ratio of 0.87, a quick ratio of 0.78 and a debt-to-equity ratio of 1.61. The stock has a market cap of $46.67 billion, a P/E ratio of 18.87, a P/E/G ratio of 2.86 and a beta of 0.39. Exelon has a 12 month low of $34.01 and a 12 month high of $48.11.

Exelon (NASDAQ:EXC) last issued its earnings results on Wednesday, February 12th. The company reported $0.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.59 by $0.05. Exelon had a net margin of 10.68% and a return on equity of 9.52%. During the same period in the previous year, the firm earned $0.60 earnings per share. As a group, equities analysts forecast that Exelon will post 2.64 EPS for the current fiscal year.

Exelon Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were paid a $0.40 dividend. The ex-dividend date of this dividend was Monday, February 24th. This represents a $1.60 annualized dividend and a dividend yield of 3.46%. This is an increase from Exelon’s previous quarterly dividend of $0.38. Exelon’s dividend payout ratio (DPR) is 65.31%.

Insider Activity at Exelon

In other news, EVP Colette D. Honorable sold 1,463 shares of the firm’s stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $40.57, for a total transaction of $59,353.91. Following the sale, the executive vice president now directly owns 2,271 shares in the company, valued at $92,134.47. This trade represents a 39.18 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 0.10% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the company. Norges Bank bought a new position in shares of Exelon in the fourth quarter worth about $479,597,000. Price T Rowe Associates Inc. MD grew its holdings in Exelon by 37.2% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 27,618,055 shares of the company’s stock valued at $1,039,545,000 after buying an additional 7,483,873 shares in the last quarter. FMR LLC raised its position in shares of Exelon by 46.9% during the fourth quarter. FMR LLC now owns 17,306,652 shares of the company’s stock valued at $651,422,000 after buying an additional 5,524,103 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of Exelon by 43.3% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 12,846,030 shares of the company’s stock worth $483,525,000 after buying an additional 3,878,687 shares in the last quarter. Finally, JPMorgan Chase & Co. boosted its position in shares of Exelon by 109.0% during the third quarter. JPMorgan Chase & Co. now owns 5,884,282 shares of the company’s stock worth $238,608,000 after acquiring an additional 3,068,309 shares during the last quarter. Institutional investors own 80.92% of the company’s stock.

Exelon Company Profile

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.